| Issue |
Section |
Title |
File |
| Vol 22, No 5 (2020) |
Articles |
Management of patients with chronic heart failure and diabetes mellitus from the standpoint of modern recommendations and in real clinical practice |
(Rus)
|
| Vol 23, No 6 (2021) |
Articles |
Dinical value of blood biomarker ST2 in patients with chronic heart failure |
(Rus)
|
| Vol 23, No 10 (2021) |
Articles |
Neopterin is a biomarker of chronic heart failure (review of modern literature) |
(Rus)
|
| Vol 24, No 1 (2022) |
Review |
Pentraxin-3 – a promising biological marker in heart failure: literature review |
(Rus)
|
| Vol 24, No 10 (2022) |
Articles |
Catestanin – a promising biological marker for heart failure: A review |
(Rus)
|
| Vol 24, No 12 (2022) |
Articles |
The role of interleukin-6 in the development of cardiovascular diseases: A review |
(Rus)
|
| Vol 25, No 1 (2023): Cardiovascular diseases |
Articles |
Endocan is a key player in cardiovascular disease: A review |
(Rus)
|
| Vol 25, No 2 (2023): Neurology and rheumatology |
Articles |
Baker's cyst: etiopathogenesis, clinical picture, differential diagnosis of complications: A review |
(Rus)
|
| Vol 25, No 10 (2023): Болезни сердца и сосудов |
Articles |
The role of interleukin-27 in atherosclerotic cardiovascular diseases: A review |
(Rus)
|
| Vol 26, No 12 (2024): Коморбидность в клинике внутренних болезней |
Articles |
Retrospective analysis of the causes of uveitis in patients of the ophthalmology department of a multidisciplinary clinic: the place of hyperuricemia |
(Rus)
|
| Vol 26, No 1 (2024): Cardiology and Nephrology |
Articles |
Fibroblast growth factor 21 (FGF21): diagnostic, prognostic and therapeutic aspects in heart failure. A review |
(Rus)
|
| Vol 26, No 10 (2024): CARDIOLOGY AND NEPHROLOGY |
Articles |
LOX-1 as a biological marker and therapeutic target in cardiovascular pathology (literature review) |
(Rus)
|
